Inhibition of α-glucosidase by aqueous extracts of some potent antidiabetic medicinal herbs

Preparative Biochemistry and Biotechnology

Volumn 35, Issue 1, 2005, Pages 29-36

  Önal, Seçil ^a   Timur, Suna ^a   Okutucu, Burcu ^a   Zihnioǧlu, Figen ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Glucosidase inhibition; Myrtus communis; Taraxacum officinale; Type 2 diabetes mellitus (NIDDM); Urtica dioica; Viscum album

Indexed keywords

ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; PLANT EXTRACT; WATER;

ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; ENZYME ACTIVATION; MEDICINAL PLANT; SOLUTION AND SOLUBILITY; SPECIES DIFFERENCE;

ALPHA-GLUCOSIDASES; ENZYME ACTIVATION; HYPOGLYCEMIC AGENTS; PLANT EXTRACTS; PLANTS, MEDICINAL; SOLUTIONS; SPECIES SPECIFICITY; WATER;

MYRTUS COMMUNIS; ORYCTOLAGUS CUNICULUS; TARAXACUM; TARAXACUM OFFICINALE; URTICA; URTICA DIOICA; VISCUM; VISCUM ALBUM;

EID: 12444306435     PISSN: 10826068     EISSN: None     Source Type: Journal    
DOI: 10.1081/PB-200041438     Document Type: Article

References (23)

1. Pirart, J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1978, 1, 168-172.
2. Chiba, S. Molecular mechanism of α-glucosidase and glucoamylase. Biosci. Biotech. Biochem. 1997, 61 (8), 1233-1239.
3. Chehade, J.M.; Mooradian, A.D. A rational approach to drug theraphy of type 2 diabetes mellitus. Diabetes Mellitus 2000, 60 (1), 95-113.
4. Bischoff, H. The mechanism of α-glucosidase inhibition in the management of diabetes. Clin. Invest. Med. 1995, 18 (4), 303-311.
5. Sima, A.A.F.; Chakrabarti, S. Long term suppression of postprandial hyperglycaemia with acorbose retards the development of neuropathies in the BB/W rat. Diabetologia 1992, 35, 325-330.
6. Sato, H.; Shiina, N. Effect of an α-glucosidase inhibitor on glomerular basement membrane anionic sites in streptozotocin induced mildly diabetic rats. Diabetes Res. Clin. Pract. 1997, 37, 91-99.
7. Toeller, M. α-Glucosidase inhibitors in diabetes efficiacy in NIDDM subjects. Eur. J. Clin. Invest. 1994, 24 (Suppl. 3), 31-35.
8. Bischoff, H. Pharmacology of α-glucosidase inhibition. Eur. J. Clin. Invest. 1994, 24 (Suppl. 3), 3-10.
9. Fuder, H.; Kleist, P.; Birkel, M.; Ehrlich, A.; Emeklibas, S.; Maslak, W.; Stridde, E.; Wetzelsberger, N.; Wieckhorst, G.; Lücker, P.W. The α-glucosidase inhibitor voglibose(AO-128) does not change pharmacodynamics or pharmacokinetics of warfarin. Eur. J. Clin. Pharmacol. 1997, 53, 153-157.
10. Saito, N.; Sakai, H.; Sekihara, H.; Yajima, Y. Effect of an α-glucosidase inhibitor (voglibose) in combination with sulphonilureas on glycaemic control in type 2 diabetes patients. J. Int. Med. Res. 1998, 26, 219-232.
11. Rury, N.; Robert, C.T.; Carole, A.C. A randomized double-blind trial of acorbose in type 2 diabetes shows improved glycaemic control over 3 years. Diabetes Care 1999, 22, 960-964.
12. Johnston, P.S.; Lebovitz, H.E.; Coniff, R.F.; Simonson, D.C.; Raskin, P.; Munera, C.L. Advantages of α-glucosidase inhibition as monotheraphy in elderly type 2 diabetic patients. J. Clin. Endocrin. Metab. 1998, 83 (5), 1515-1522.
13. Coniff, R.F.; Johnston, P.S.; Knowles, L.; Krol, A. Long term effects of the α-glucosidase inhibitor miglitol (BAY m1099) in NIDDM patient treated with maximum dose sulfonylurea. Diabetes 1996, 45 (Suppl. 2), 221A.
14. Mehta, A.; Zitzmann, N.; Rudd, P.M.; Block, T.M.; Dwek, R.A. α-Glucosidase inhibitors as potential broad based antiviral agents. FEBS Lett. 1998, 430, 17-22.
15. Watanabe, J.; Kawabata, J.; Kurihara, H.; Niri, R. Isolation and identification of α-glucosidase inhibitors from tochu-cha (Eucommia ulmoides). Biosci. Biotech. Biochem. 1997, 61 (1), 177-178.
16. Yoshikawa, M.; Murakami, T.; Shimada, H.; Matsuda, H.; Yamahara, J.; Tanabe, G.; Muraoka, O. Salacinol, potent antidiabetic principle with unique thiosugar sulfonium sulfate structure from the ayurvedic traditional medicine Salaciareticulata in SriLanka and India. Tetrahedr. Lett. 1997, 38, 8367-8370.
17. Matsui, T.; Yoshimoto, C.; Osajima, K.; Oki, T.; Osajima, Y. Invitro survey of α-glucosidase inhibitory food components. Biosci. Biotech. Biochem. 1996, 60(12), 2019-2022.
18. Lowry, O.H.; Rosebrough, N.J.; Farr, A.L.; Randall, R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
19. Saha, S.K.; Brewer, C.F. Determination of the concentrations of oligosaccharides, complex type carbohydrates and glycoproteins using the phenol sulfuric acid method. Carbohydr. Res. 1994, 254, 157-163.
20. Kamada, Y.; Asano, N.; Yoshikawa, M.; Tagaguchi, M. A new α-glucosidase inhibiting aminocyclitol produced by streptomyces hygroscopicus. J. Antibiot. 1984, 87, 1301-1308.
21. Oki, T.; Matsui, T.; Osajima, Y. Inhibitory effect of α-glucosidase inhibitors varies according to its origin. J. Agric. Food. Chem. 1999, 47, 550-553.
22. Nishioka, T.; Watanabe, J.; Kawabata, J.; Niki, R. Isolation and activity of N-p-coumaryltyramine, an α-glucosidase inhibitor in welsh onion (Allium fistulosum). Biosci. Biotech. Biochem. 1997, 61, 1138-1141.
23. Hiroyuki, F.; Tomohide, Y.; Kazunori, O. Efficiacy and safety of Touchi extract, an α-glucosidase inhibitor derived from fermented soybeans, in non insulin dependent diabetic mellitus. J. Nutr. Biochem. 2001, 12, 351-356.